282 related articles for article (PubMed ID: 10226553)
21. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
22. Effect of Medrogestone on 17beta-hydroxysteroid dehydrogenase activity in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines.
Chetrite GS; Ebert C; Wright F; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):51-6. PubMed ID: 10215037
[TBL] [Abstract][Full Text] [Related]
23. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines.
Falany JL; Falany CN
Cancer Res; 1996 Apr; 56(7):1551-5. PubMed ID: 8603401
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
Dembinski TC; Leung CK; Shiu RP
Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
[TBL] [Abstract][Full Text] [Related]
25. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.
van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH
J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135
[TBL] [Abstract][Full Text] [Related]
26. JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells.
Altiok N; Koyuturk M; Altiok S
Breast Cancer Res Treat; 2007 Nov; 105(3):247-54. PubMed ID: 17187235
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Werner HM; Franke HR; Vermes I
Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
[TBL] [Abstract][Full Text] [Related]
28. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
[TBL] [Abstract][Full Text] [Related]
29. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
[TBL] [Abstract][Full Text] [Related]
30. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice.
Leung CK; Shiu RP
Cancer Res; 1981 Feb; 41(2):546-51. PubMed ID: 7448802
[TBL] [Abstract][Full Text] [Related]
31. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
32. Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines.
Le Bail JC; Allen K; Nicolas JC; Habrioux G
Anticancer Res; 1998; 18(3A):1683-8. PubMed ID: 9673390
[TBL] [Abstract][Full Text] [Related]
33. Altered response to thyroid hormones by breast and ovarian cancer cells.
Martinez MB; Ruan M; Fitzpatrick LA
Anticancer Res; 2000; 20(6B):4141-6. PubMed ID: 11205239
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women.
Elsadig RE; Reimann K; Yip CH; Lai LC
Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341
[TBL] [Abstract][Full Text] [Related]
35. Estradiol as an anti-aromatase agent in human breast cancer cells.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):12-7. PubMed ID: 16413774
[TBL] [Abstract][Full Text] [Related]
36. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
37. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
ter Haar E; Day BW
Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
[TBL] [Abstract][Full Text] [Related]
38. Effect of breast cyst fluid on oestrone sulphatase activity in MCF-7 breast cancer cells.
Erbas H; Lennard TW; Lai LC
Anticancer Res; 1996; 16(2):833-6. PubMed ID: 8687137
[TBL] [Abstract][Full Text] [Related]
39. Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells.
Nozawa T; Suzuki M; Takahashi K; Yabuuchi H; Maeda T; Tsuji A; Tamai I
J Pharmacol Exp Ther; 2004 Dec; 311(3):1032-7. PubMed ID: 15328376
[TBL] [Abstract][Full Text] [Related]
40. Estrogen sulfotransferases in breast and endometrial cancers.
Pasqualini JR
Ann N Y Acad Sci; 2009 Feb; 1155():88-98. PubMed ID: 19250196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
